Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients After Chemoradiation: Its Clinical Implications

BACKGROUND: We have limited knowledge of the geographic distribution of resistant EAC in the resected specimen and its clinical importance can be enormous. METHOD: We selected patients with baseline stage III EAC who had chemoradiation followed by surgery, and had residual EAC (resistant cases only)...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncology
Main Authors: Neishaboori, Nastaran, Wadhwa, Roopma, Nogueras-González, Graciela M., Elimova, Elena, Shiozaki, Hironori, Sudo, Kazuki, Charalampakis, Nikolaos, Hiremath, Adarsh, Lee, Jeffrey H., Bhutani, Manoop S., Weston, Brian, Blum, Mariela A., Rogers, Jane E., Garris, Jeana L., Rice, David C., Komaki, Ritsuko, Swisher, Stephen G., Skinner, Heath D., Hofstetter, Wayne L., Ajani, Jaffer A.
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4498973/
https://ncbi.nlm.nih.gov/pubmed/25765719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000371889
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares